• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Timing of surgery in patients with aneurysmal subarachnoid haemorrhage: rebleeding is still the major cause of poor outcome in neurosurgical units that aim at early surgery.动脉瘤性蛛网膜下腔出血患者的手术时机:在旨在早期手术的神经外科病房,再出血仍是导致预后不良的主要原因。
J Neurol Neurosurg Psychiatry. 1997 Oct;63(4):490-3. doi: 10.1136/jnnp.63.4.490.
2
Timing of surgery for supratentorial aneurysmal subarachnoid haemorrhage: report of a prospective study.幕上动脉瘤性蛛网膜下腔出血的手术时机:一项前瞻性研究报告
J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):480-4. doi: 10.1136/jnnp.72.4.480.
3
Timing of aneurysm surgery in subarachnoid haemorrhage--an observational study in The Netherlands.蛛网膜下腔出血时动脉瘤手术的时机——荷兰的一项观察性研究
Acta Neurochir (Wien). 2005 Aug;147(8):815-21. doi: 10.1007/s00701-005-0536-0. Epub 2005 Jun 16.
4
Outcome from poor grade aneurysmal subarachnoid haemorrhage--which poor grade subarachnoid haemorrhage patients benefit from aneurysm clipping?低级别动脉瘤性蛛网膜下腔出血的预后——哪些低级别蛛网膜下腔出血患者能从动脉瘤夹闭术中获益?
Br J Neurosurg. 2000 Apr;14(2):105-9. doi: 10.1080/02688690050004516.
5
Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage.持续性围手术期高血糖作为动脉瘤性蛛网膜下腔出血后不良预后的独立预测因素。
J Neurosurg. 2007 Dec;107(6):1080-5. doi: 10.3171/JNS-07/12/1080.
6
Causes of poor outcome in patients admitted with good-grade subarachnoid haemorrhage.入院时病情分级良好的蛛网膜下腔出血患者预后不良的原因。
Acta Neurochir (Wien). 2017 Mar;159(3):559-565. doi: 10.1007/s00701-017-3081-8. Epub 2017 Jan 20.
7
Prognostic value of premorbid hypertension and neurological status in aneurysmal subarachnoid hemorrhage: pooled analyses of individual patient data in the SAHIT repository.病前高血压和神经状态在动脉瘤性蛛网膜下腔出血中的预后价值:SAHIT数据库中个体患者数据的汇总分析
J Neurosurg. 2015 Mar;122(3):644-52. doi: 10.3171/2014.10.JNS132694. Epub 2015 Jan 2.
8
Overall outcome in aneurysmal subarachnoid hemorrhage. A prospective study from neurosurgical units in Sweden during a 1-year period.动脉瘤性蛛网膜下腔出血的总体预后。瑞典神经外科单位为期1年的前瞻性研究。
J Neurosurg. 1992 May;76(5):729-34. doi: 10.3171/jns.1992.76.5.0729.
9
The impact of the international subarachnoid aneurysm trial (ISAT) on the management of aneurysmal subarachnoid haemorrhage in a neurosurgical unit in the UK.国际蛛网膜下腔动脉瘤试验(ISAT)对英国一家神经外科单位中动脉瘤性蛛网膜下腔出血管理的影响。
Clin Neurol Neurosurg. 2006 Feb;108(2):117-23. doi: 10.1016/j.clineuro.2005.11.001. Epub 2005 Dec 20.
10
Outcome after In-Hospital Rebleeding of Rupture of Intracranial Aneurysms.颅内动脉瘤破裂后院内再出血的结局
J Neurol Surg A Cent Eur Neurosurg. 2016 May;77(3):207-21. doi: 10.1055/s-0035-1570007. Epub 2016 Jan 25.

引用本文的文献

1
Impact of time to start of tranexamic acid treatment on rebleed risk and outcome in aneurysmal subarachnoid hemorrhage.氨甲环酸治疗开始时间对动脉瘤性蛛网膜下腔出血再出血风险和结局的影响。
Eur Stroke J. 2024 Sep;9(3):658-666. doi: 10.1177/23969873241246591. Epub 2024 Apr 12.
2
Risk factors for poor outcome after aneurysmal subarachnoid hemorrhage in patients with initial favorable neurological status.初始神经功能状态良好的动脉瘤性蛛网膜下腔出血患者预后不良的危险因素。
Acta Neurochir (Wien). 2024 Feb 20;166(1):93. doi: 10.1007/s00701-024-05968-5.
3
Length of Survival, Outcome, and Potential Predictors in Poor-Grade Aneurysmal Subarachnoid Hemorrhage Patients Treated with Microsurgical Clipping.接受显微夹闭治疗的低分级破裂性蛛网膜下腔出血患者的生存时间、结局和潜在预测因素。
CNS Neurol Disord Drug Targets. 2024;23(9):1157-1166. doi: 10.2174/0118715273258678231011060312.
4
The efficacy of antifibrinolytic therapy in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.抗纤维蛋白溶解疗法在动脉瘤性蛛网膜下腔出血中的疗效:一项系统评价和荟萃分析。
Future Sci OA. 2023 May 16;9(6):FSO866. doi: 10.2144/fsoa-2023-0014. eCollection 2023 Jul.
5
Evaluation of clinical parameters of patients with aneurysmal subarachnoid hemorrhage during long-distance interhospital transport.评价动脉瘤性蛛网膜下腔出血患者长途院间转运期间的临床参数。
Ulus Travma Acil Cerrahi Derg. 2022 Oct;28(10):1488-1493. doi: 10.14744/tjtes.2021.28035.
6
DIAGNOSTIC AND THERAPEUTIC DILEMMAS IN THE MANAGEMENT OF INTRACRANIAL ANEURYSMS.颅内动脉瘤诊治中的诊断和治疗困境。
Acta Clin Croat. 2021 Dec;60(4):758-764. doi: 10.20471/acc.2021.60.04.24.
7
Systolic Blood Pressure Variability is a Novel Risk Factor for Rebleeding in Acute Subarachnoid Hemorrhage: A Case-Control Study.收缩压变异性是急性蛛网膜下腔出血再出血的一个新的危险因素:一项病例对照研究。
Medicine (Baltimore). 2016 Mar;95(11):e3028. doi: 10.1097/MD.0000000000003028.
8
Factors and outcomes associated with ultra-early surgery for poor-grade aneurysmal subarachnoid haemorrhage: a multicentre retrospective analysis.低分级动脉瘤性蛛网膜下腔出血超早期手术的相关因素及预后:一项多中心回顾性分析
BMJ Open. 2015 Apr 15;5(4):e007410. doi: 10.1136/bmjopen-2014-007410.
9
Considerations about ultra-early treatment of ruptured aneurysms.关于破裂动脉瘤超早期治疗的思考
Neurocrit Care. 2014 Aug;21(1):1-3. doi: 10.1007/s12028-014-0002-z.
10
Time intervals from subarachnoid hemorrhage to rebleed.蛛网膜下腔出血到再出血的时间间隔。
J Neurol. 2014 Jul;261(7):1425-31. doi: 10.1007/s00415-014-7365-0. Epub 2014 May 8.

本文引用的文献

1
An audit of aneurysmal subarachnoid haemorrhage: earlier resuscitation and surgery reduces inpatient stay and deaths from rebleeding.一项关于动脉瘤性蛛网膜下腔出血的审计:早期复苏和手术可减少住院时间及再出血导致的死亡。
J Neurol Neurosurg Psychiatry. 1996 Mar;60(3):301-6. doi: 10.1136/jnnp.60.3.301.
2
Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand.甲磺酰替拉扎特治疗动脉瘤性蛛网膜下腔出血患者的随机、双盲、安慰剂对照试验:欧洲、澳大利亚和新西兰的一项合作研究
J Neurosurg. 1996 Feb;84(2):221-8. doi: 10.3171/jns.1996.84.2.0221.
3
Clinical course of spontaneous subarachnoid hemorrhage: a population-based study in King County, Washington.自发性蛛网膜下腔出血的临床病程:华盛顿州金县的一项基于人群的研究
Neurology. 1993 Apr;43(4):712-8. doi: 10.1212/wnl.43.4.712.
4
Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage.初次出血和再出血是蛛网膜下腔出血后主要的死亡原因。
Stroke. 1994 Jul;25(7):1342-7. doi: 10.1161/01.str.25.7.1342.
5
Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.动脉瘤性蛛网膜下腔出血管理指南。美国心脏协会卒中委员会特别写作组给医疗专业人员的声明。
Stroke. 1994 Nov;25(11):2315-28. doi: 10.1161/01.str.25.11.2315.
6
Aneurysmal bleeding. A plea for early surgery in good-risk patients.动脉瘤性出血。呼吁对高危患者尽早进行手术。
Acta Neurochir (Wien). 1994;128(1-4):126-31. doi: 10.1007/BF01400662.
7
Antifibrinolytic treatment in subarachnoid hemorrhage.蛛网膜下腔出血的抗纤溶治疗
N Engl J Med. 1984 Aug 16;311(7):432-7. doi: 10.1056/NEJM198408163110703.
8
Natural history of subarachnoid hemorrhage, intracranial aneurysms and arteriovenous malformations.蛛网膜下腔出血、颅内动脉瘤和动静脉畸形的自然病史。
J Neurosurg. 1966 Sep;25(3):321-68. doi: 10.3171/jns.1966.25.3.0321.
9
Assessment of coma and impaired consciousness. A practical scale.昏迷与意识障碍评估。实用量表。
Lancet. 1974 Jul 13;2(7872):81-4. doi: 10.1016/s0140-6736(74)91639-0.
10
Antifibrinolytics in subarachnoid hemorrhage. Do they have a role? No.蛛网膜下腔出血中的抗纤溶药物。它们有作用吗?没有。
Arch Neurol. 1987 Jan;44(1):116-8. doi: 10.1001/archneur.1987.00520130090025.

动脉瘤性蛛网膜下腔出血患者的手术时机:在旨在早期手术的神经外科病房,再出血仍是导致预后不良的主要原因。

Timing of surgery in patients with aneurysmal subarachnoid haemorrhage: rebleeding is still the major cause of poor outcome in neurosurgical units that aim at early surgery.

作者信息

Roos Y B, Beenen L F, Groen R J, Albrecht K W, Vermeulen M

机构信息

Department of Neurology, Academic Medical Centre, University of Amsterdam, The Netherlands.

出版信息

J Neurol Neurosurg Psychiatry. 1997 Oct;63(4):490-3. doi: 10.1136/jnnp.63.4.490.

DOI:10.1136/jnnp.63.4.490
PMID:9343129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2169792/
Abstract

OBJECTIVE

To investigate prospectively the proportion of patients actually operated on early in units that aim at surgery in the acute phase of aneurysmal subarachnoid haemorrhage (SAH) and what is the main current determinant of poor outcome.

METHODS

A prospective analysis of all SAH patients admitted during a one year period at three neurosurgical units that aim at early surgery. The following clinical details were recorded: age, sex, date of SAH, date of admission to the neurosurgical centre, whether a patient was referred by a regional hospital or a general practitioner, Glasgow coma scale and grade of SAH (World Federation of Neurological Surgeons (WFNS) score) on admission at the neurosurgical unit, results of CT and CSF examination, the presence of an aneurysm on angiography, details of treatment with nimodipine or antifibrinolytic agents, and the date of surgery to clip the aneurysm. At follow up at three months, the patients' clinical outcome was determined with the Glasgow outcome scale and in cases of poor outcome the cause for this was recorded.

RESULTS

The proportion of patients that was operated on early--that is, within three days after SAH--was 55%. Thirty seven of all 102 admitted patients had a poor outcome. Rebleeding and the initial bleeding were the main causes of this in 35% and 32% respectively of all patients with poor outcome.

CONCLUSIONS

In neurosurgical units with what has been termed "modern management" including early surgery, about half of the patients are operated on early. Rebleeding is still the major cause of poor outcome.

摘要

目的

前瞻性研究在旨在对动脉瘤性蛛网膜下腔出血(SAH)急性期进行手术的单位中,实际早期接受手术治疗的患者比例,以及目前导致预后不良的主要决定因素是什么。

方法

对三家旨在进行早期手术的神经外科单位在一年期间收治的所有SAH患者进行前瞻性分析。记录以下临床细节:年龄、性别、SAH日期、入住神经外科中心的日期、患者是由地区医院还是全科医生转诊、入住神经外科单位时的格拉斯哥昏迷量表评分和SAH分级(世界神经外科医师联合会(WFNS)评分)、CT和脑脊液检查结果、血管造影显示的动脉瘤情况、尼莫地平或抗纤溶药物的治疗细节以及夹闭动脉瘤的手术日期。在三个月的随访中,用格拉斯哥预后量表确定患者的临床结局,对于预后不良的病例记录其原因。

结果

早期接受手术治疗的患者比例,即SAH后三天内接受手术的患者比例为55%。在所有102例入院患者中,37例预后不良。再出血和初次出血分别是所有预后不良患者中35%和32%的主要原因。

结论

在采用包括早期手术在内的所谓“现代管理”的神经外科单位中,约一半的患者早期接受了手术。再出血仍然是预后不良的主要原因。